Table 4 Clinicopathological outcomes
TDT group (n = 33) | CMS group (n = 26) | p value | |
|---|---|---|---|
Tumor size, cm (range)* | 4.5 (3.0–9.0) | 5.5 (3.5–11.0) | 0.008 |
Histological type (%) | 0.470 | ||
Tub 1 | 11 (33.3) | 7 (26.9) | |
Tub 2 | 20 (60.7) | 16 (61.6) | |
Por | 1 (3.0) | 1 (3.8) | |
Muc | 0 (0) | 2 (7.7) | |
Sci | 1 (3.0) | 0 (0) | |
Stage (%) | 0.441 | ||
II | 11 (33.3) | 11 (42.3) | |
III | 11 (33.3) | 6 (23.1) | |
IV | 11 (33.3) | 9 (34.6) | |
Lymph nodes, n (range)* | 9 (1–23) | 19 (6–40) | < 0.01 |
Resection status (%) | < 0.01 | ||
D1 | 3 (9.1) | 0 (0) | |
D2 | 12 (36.4) | 1 (3.8) | |
D3 | 18 (54.5) | 25 (96.2) | |
Recurrence (%) | 0.424 | ||
Yes | 9 (40.9) | 4 (23.5) | |
No | 13 (59.1) | 13 (76.5) | |
Observation period, days (range)* | 1516 (17–4773) | 608 (52–1601) | |